Rifampicin (Rifadin) cap 300 mg: Supply issue resolved

Supply issue Active

Sanofi has had an out of stock of rifampicin cap 300 mg (Pharmacode: 251194).

28 August 2025 | Product arrived with supplier

Sanofi has received the next shipment and stock is going out to wholesalers. It can take another 1 to 2 weeks for stock to reach pharmacies around New Zealand Aotearoa.

Affected product

Due to delays to a recent shipment of rifampicin capsules, the supplier has run out of the following product.

  • Chemical: Rifampicin
  • Presentation: Cap 300 mg
  • Brand: Rifadin
  • Pharmacode: 251194 
  • Subsidy: $122.06
  • Measure / Qty: per 100

Schedule listing for rifampicin(external link)

Alternatives 

We have received clinical advice that 2 x 150 mg can be used in place of the 300 mg capsule. 

We're sorry, we know that taking multiple tablets is not ideal. As the next shipment is due before the end of the month, we hope any disruption is minimal.

Resupplied end of August 2025

Sanofi has received the next shipment and stock is going out to wholesalers. It can take another 1 to 2 weeks for stock to reach pharmacies around New Zealand Aotearoa.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)